Emergency Medicine Doctors in Ann Arbor, MI Accepting Medicare

193 Emergency Medicine doctors found. Showing 101 - 120

Anne E. Schutter, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2000 Green Road, Suite 100, Ann Arbor, MI 48105 Phone: 734-995-3764    Fax: 208-475-9028

Michael D. Burke, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2000 Green Rd., Suite 100, Ann Arbor, MI 48105 Phone: 734-995-3764    Fax: 208-475-9028

Edward Allen Walton, MD Emergency Medicine - Pediatric Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 East Medical Center Dr, B1 Floor University Hospital Recp Emergency, Ann Arbor, MI 48109 Phone: 734-936-6666

Helena Hai-ling Wang-flores, DO Emergency Medicine - Pediatric Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000

John G Younger, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, B1 Floor University Hospital Recp Emergency, Ann Arbor, MI 48109 Phone: 734-936-6666

Harini Vijay, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000

Ronald F Maio, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, B1 Floor Taubman Center Recp Emos, Ann Arbor, MI 48109 Phone: 734-232-2867    Fax: 734-232-2800

Florian Frowin Schmitzberger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000

Karima Al-wakya Lelak, M.D. Emergency Medicine - Pediatric Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000

Dr. Renee M Nilan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4200 Whitehall Dr Ste 150, Ann Arbor, MI 48105 Phone: 734-995-0308    Fax: 734-995-0425

Brian Jeffrey Zink, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, B1 Floor University Hospital Recp Emergency, Ann Arbor, MI 48109 Phone: 734-936-6666

Lauren Elizabeth Mamer, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000

Jessica Koehler, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000

Dr. Nichole Kathleen Lavanway, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, B1-380 Tc, Ann Arbor, MI 48109 Phone: 734-763-7919    Fax: 734-763-9298

Dr. Patrick James Maier, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E. Medical Center Drive, B1-380 Tc, Ann Arbor, MI 48109 Phone: 734-763-7919    Fax: 734-763-9298

Dr. Rodney Omron, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, B1 Floor University Hospital Recp Emergency, Ann Arbor, MI 48109 Phone: 734-936-6666

Allison Dawn Cator, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, 2nd Floor C.s. Mott Childrens Hospital, Ann Arbor, MI 48109 Phone: 734-936-4230    Fax: 734-998-0037

Dr. Stephen Paul Heirendt, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Green Road - Epmg, Suite 300, Ann Arbor, MI 48105 Phone: 734-995-3764

Dr. Kalavathy K Srinivasan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 East Medical Center Dr, B1 Floor University Hospital Recp Emergency, Ann Arbor, MI 48109 Phone: 734-936-6666

Stuart Vanderheide, MD Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 2366 Oak Valley Dr, Ann Arbor, MI 48103 Phone: 877-227-8823

News Archive

New data on Merck's odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on odanacatib, an investigational cathepsin-K (Cat-K) inhibitor in development for the treatment of osteoporosis in postmenopausal women, were presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, Canada.

Preliminary results from Nektar Therapeutics' NKTR-102 Phase 2 study in platinum-resistant ovarian cancer

Nektar Therapeutics today announced preliminary results from the first stage of a two-stage Phase 2 clinical study evaluating NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients enrolled with platinum-resistant disease were evaluable for the primary endpoint of overall response rate using Gynecologic Cancer InterGroup (GCIG) criteria, i.e., a combination of response by tumor imaging

Federal health care reform legislation can help removing financial barriers to treat Americans

New government data released today demonstrate the continued, urgent need for more Americans to have access to drug and alcohol addiction treatment, according to an analysis by the Closing the Addiction Treatment Gap (CATG) initiative. If implemented properly, federal health care reform legislation could help remove financial barriers to treatment for millions of Americans.

Study: Using best-practice approach could lead to big cost reductions in hospitals nationwide

A major challenge facing today's health care community is to find ways to lower costs without compromising clinical quality. Taking that challenge to task, researchers at Medstar Health and Georgetown University School of Medicine, Washington DC, report success in using a concept called "value-based analysis," which simultaneously measures quality and cost and addresses inefficiencies in care.

Duke receives approval to initiate NPC-1C Phase I trial for advanced pancreatic and colorectal cancer

Neogenix Oncology, Inc. announced today that researchers at Duke University Medical Center have received approval to move forward with a Phase I trial of the company's lead therapeutic antibody, NPC-1C, in patients with advanced stage pancreatic or colorectal cancer. Duke joins Johns Hopkins Hospital which is already conducting the Phase I trial of NPC-1C. In addition to Johns Hopkins, North Shore - LIJ has also enrolled patients on this multi-center study.

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3
• 4
• 5
• 6(current)
• 7
• 8
• 9
• 10